Go to my den... indeed
Nov 2016 this company made a strategic unpredictable shift from breasts to acne, TRUST US
Fast forward a year and they file a 40m shelf to ADVANCE CLINICALS ON BPX-01 (the acne drug with tainted phase 2)
Advance clinical could mean anything, they did not state PHASE 3, could have planned a phase 2 redo.
Seems the SEC shot down 40m (phase 3 est at 25 to 30m dollars by bpmx in june) because they have filed an AMENDED S1, all of this is as I WARNED EVERYONE.
The AMENDED S1A does not MENTION BPX-01, instead, they SHIFT STRATEGY to BPX-04 for Rosacea, which I also predicted was a possibility based on their past performance, and warned all about,
The amended filing is for LESS THAN HALF of what they wanted and they state that INVESTORS WILL BE DILUTED TO 11 CENTS which once again, I warned would bring this stock to 8.5 pennies in November.
Now I will go back in my den and lmfao at all the idiots that bought this during the recent pump and dump, and the longs that didnt take that opp to bail out after I warned them and posted all they needed to have to see the obvious.
